The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Open accessPublished version of a preprint
Abstract
BACKGROUND: The relationship between the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains unclear. METHODS: We investigated the incidence of SARS-CoV-2 infection confirmed by polymerase chain reaction (PCR) in seropositive and seronegative health care workers attending testing of asymptomatic and symptomatic staff at Oxford University Hospitals in the United Kingdom. Baseline antibody status was determined by anti-spike (primary analysis) and anti-nucleocapsid IgG assays, and staff members were followed for up to 31 weeks. We estimated the relative incidence of PCR-positive test results and new symptomatic infection according to antibody status, adjusting for age, participant-reported gender, and changes in incidence over time. RESULTS: A total of 12,541 health care workers participated and had anti-spike IgG measured; 11,364 were followed up after negative antibody results and 1265 after positive results, including 88 in whom seroconversion occurred during follow-up. A total of 223 anti-spike-seronegative health care workers had a positive PCR test (1.09 per 10,000 days at risk), 100 during screening while they were asymptomatic and 123 while symptomatic, whereas 2 anti-spike-seropositive health care workers had a positive PCR test (0.13 per 10,000 days at risk), and both workers were asymptomatic when tested (adjusted incidence rate ratio, 0.11; 95% confidence interval, 0.03 to 0.44; P = 0.002). There were no symptomatic infections in workers with anti-spike antibodies. Rate ratios were similar when the anti-nucleocapsid IgG assay was used alone or in combination with the anti-spike IgG assay to determine baseline status. CONCLUSIONS: The presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months. (Funded by the U.K. Government Department of Health and Social Care and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This study estimated that seropositivity at enrolment reduced the incidence of detected reinfection by almost 89% over a median follow-up of 139 days.”
From Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection (2021) · cites this paper as [53]
In the citing paper
“a level of protection that is not significantly different to the 89–95% protection that has been estimated following natural infection53,54.”
From Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection (2021) · cites this paper as [53]
In the citing paper
“Preexisting immunity to SARS-CoV-2 is associated with protection against reinfection in humans (9–11) and in nonhuman primates (12, 13).”
From mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection (2021) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
To, K. K., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C., Cai, J., Chan, J. M., Chik, T. S., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,045
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
Seow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Wajnberg, A., Amanat, F., Firpo, A., Altman, D. R., Bailey, M. J., Mansour, M., McMahon, M., Meade, P., Mendu, D. R., Muellers, K., et al. (2020) · Science · doi:10.1126/science.abd7728 · Cited by 1,195
Humoral Immune Response to SARS-CoV-2 in Iceland
Gudbjartsson, D. F., Norddahl, G. L., Melsted, P., Gunnarsdottir, K., Holm, H., Eythorsson, E., Arnthorsson, A. O., Helgason, D., Bjarnadottir, K., Ingvarsson, R. F., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2026116 · Cited by 903
Vaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829
Genomic evidence for reinfection with SARS-CoV-2: a case study
Tillett, R. L., Sevinsky, J. R., Hartley, P. D., Kerwin, H., Crawford, N. F., Gorzalski, A. J., Laverdure, C., Verma, S. C., Rossetto, C. C., Jackson, D. K., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30764-7 · Cited by 755
To, K. K.-W., Hung, I. F.-N., Ip, J. D., Chu, A. W.-H., Chan, W.-M., Tam, A. R., Fong, C. H.-Y., Yuan, S., Tsoi, H.-W., Ng, A. C.-K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1275 · Cited by 746
Addetia, A., Crawford, K. H. D., Dingens, A., Zhu, H., Roychoudhury, P., Huang, M.-L., Jerome, K. R., Bloom, J. D., & Greninger, A. L. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02107-20 · Cited by 525
Flagged first, then by citations
Research works printed but not linked: 2
- Muecksch F, Wise H, Batchelor B, et al. Longitudinal analysis of serology and neutralizing antibody levels in COVID19 convalescents. J Infect Dis 2020 November 3 (Epub ahead of print).33140086
- To KK-W, Hung IF-N, Ip JD, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis 2020 August 25 (Epub ahead of print).32840608
Cited by
Sorted by citations
Items 401–500 of 913
Swadźba, J., Anyszek, T., Panek, A., Chojęta, A., Wyrzykowska, K., & Martin, E. (2022) · Diagnostics · doi:10.3390/diagnostics12061426 · Cited by 12
Chisanga, M., Stuible, M., Gervais, C., L’Abbé, D., Cass, B., Bisson, L., Pelletier, A., Lord‐Dufour, S., Durocher, Y., Boudreau, D., et al. (2022) · Sensors & Diagnostics · doi:10.1039/d2sd00073c · Cited by 16
Jefferson, E., Cole, C., Mumtaz, S., Cox, S., Giles, T. C., Adejumo, S., Urwin, E., Lea, D., Macdonald, C., Best, J., et al. (2022) · Journal of Medical Internet Research · doi:10.2196/40035 · Cited by 12
Self-citationHu, W., Cai, H., Yan, H.-C., Wang, H., Sun, H., Wei, Y., & Hao, Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1353415 · Cited by 12
Carreño, J. M., Mendu, D. R., Simon, V. R., Shariff, M. A., Singh, G., Menon, V. P., & Krammer, F. (2021) · iScience · doi:10.1016/j.isci.2021.102937 · Cited by 12
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
Duerr, R., Crosse, K. M., Valero-Jimenez, A. M., & Dittmann, M. (2021) · Microorganisms · doi:10.3390/microorganisms9071389 · Cited by 12
Soldatov, A. A., Kryuchkov, N. A., Витальевич, Г. Д., Авдеева, Ж. И., Свитич, О. А., & Soshnikov, S. S. (2025) · Vaccines · doi:10.3390/vaccines13080789 · Cited by 12
Alshukairi, A. N., Tolah, A. M., Dada, A. M., Al‐Tawfiq, J. A., Almagharbi, R. S., Saeedi, M. F., Al-Hamzi, M. A., El-Kafrawy, S. A., Bahaudden, H. A., El‐Saed, A., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.05.027 · Cited by 11
Serum antibody response to BNT162b2 after natural SARS‐CoV‐2 infection
Perkmann, T., Perkmann‐Nagele, N., Köller, T., Mucher, P., Radakovics, A., Wolzt, M., Wagner, O. F., Binder, C. J., & Haslacher, H. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13632 · Cited by 11
Prevalence and persistence of SARS-CoV2 antibodies among healthcare workers in Oman
Al-Naamani, K. M., Al-Jahdhami, I., Al-Tamtami, W., Al-Amri, K., Al-Khabori, M. K., Al‐Sinani, S., Said, E. A., Omer, H., Al-Bahluli, H., Al-Ryiami, S., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.09.006 · Cited by 12
Recurrent SARS-CoV-2 infections and their potential risk to public health – a systematic review
Abrokwa, S. K., Müller, S. A., Méndez-Brito, A., Hanefeld, J., & Bcheraoui, C. E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261221 · Cited by 11
Dávila‐Conn, V., Soto-Nava, M., Caro-Vega, Y. N., Paz‐Juárez, H. E., García‐Esparza, P., Tapia‐Trejo, D., Pérez‐García, M., Belaunzarán-Zamudio, P. F., Reyes‐Terán, G., Sierra-Madero, J. G., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264964 · Cited by 11
Kim, Y., Bae, J., Kwon, K. T., Chang, H., Lee, W. K., Park, H., Kim, J., Choi, I., Park, M., & Kim, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-17605-1 · Cited by 12
Kubale, J., Gleason, C., Carreño, J. M., Srivastava, K., Singh, G., PARIS Study Team, Gordon, A., Krammer, F., Simon, V. R., Alshammary, H., et al. (2022) · mBio · doi:10.1128/mbio.01784-22 · Cited by 12
Ishizaki, A., Bi, X., Nguyen, Q. T., Maeno, T., Hara, A., Nakamura, H., Kuramoto, S., Nishi, K., Ooe, H., & Ichimura, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273712 · Cited by 11
Collatuzzo, G., Lodi, V., Feola, D., Palma, G. D., Sansone, E., Sala, E., Janke, C., Castelletti, N., Porru, S., Spiteri, G., et al. (2022) · Viruses · doi:10.3390/v14122657 · Cited by 11
Wang, Y., Li, J., Zhang, W., Liu, S., Miao, L., Li, Z., Fu, A., Bao, J., Huang, L., Zheng, L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152695 · Cited by 11
Disparities of SARS-CoV-2 Nucleoprotein-Specific IgG in Healthcare Workers in East London, UK
Choudhry, N., Drysdale, K., Usai, C., Leighton, D., Sonagara, V. J., Buchanan, R., Nijjar, M., Thomas, S., Hopkins, M. J., Cutiño‐Moguel, T., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.642723 · Cited by 11
Veríssimo, C. D. M., O'Brien, C. L., Corrales, J. L., Dorey, A., Cwiklinski, K., Lalor, R., Doyle, J. M., Field, S., Masterson, C. H., Martínez, E. R., et al. (2021) · Epidemiology and Infection · doi:10.1017/s0950268821001308 · Cited by 11
Armstrong, J. N., Campbell, L., Rabatsky-Her, T., Leung, V., & Parikh, S. (2021) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2021.100054 · Cited by 11
Ireland, G., Jeffery-Smith, A., Zambon, M. C. F. A., Höschler, K., Harris, R., Poh, J., Baawuah, F., Beckmann, J., Okike, I. O., Ahmad, S. S. Y., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101150 · Cited by 11
Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients
Guzmán-Martínez, O., Guardado, K., Cardoso, M. V., Trujillo-Rivera, A., Marı́n-Hernández, A., León, M. C. O., Gómez-Ñañez, I., Gutiérrez, M., Espinosa, R., Sampieri, C. L., et al. (2021) · Infection · doi:10.1007/s15010-021-01705-7 · Cited by 12
Sherman, A. C., Desjardins, M., & Baden, L. R. (2021) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2021.10.008 · Cited by 11
Alshami, A., Attas, R. A. A., Anan, H., Maghrabi, A. A., Ghandorah, S. S., Mohammed, A., Alhalimi, A. A., Al-Jishi, J. M., & Alqahtani, H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.770727 · Cited by 12
Lanata, C. F., Gil, A. M., Ecker, L., Cornejo, R., Rios, S., Ochoa, M., Peña, B., Flores, O., Howard, L. M., & Grijalva, C. G. (2021) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12952 · Cited by 11
Pilmis, B., Elkaibi, I., de Ponfilly, G. P., Daikha, H., Bouzid, A., Guihot, A., Castreau, N., Pradère, P., Ketatni, H., Mondragon, A., et al. (2022) · Infectious Diseases Now · doi:10.1016/j.idnow.2022.01.004 · Cited by 11
Tuells, J., Parra-Grande, M., Santos-Calle, F. J., Montagud, A. C., Egoavil, C. M., García-Rivera, C., Caballero, P., Bravo, E. M. G., Rodrı́guez, J. C., & Sánchez, J. A. H. (2022) · Vaccines · doi:10.3390/vaccines10040510 · Cited by 12
Phillips, E., Adele, S., Malone, T., Deeks, A. S., Stafford, L., Dobson, S. L., Amini, A., Skelly, D., Eyre, D. W., Jeffery, K. J., et al. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac042 · Cited by 11
Self-citationIsmail, N. F., Rahman, A. E., Kulkarni, D., Zhu, F., Wang, X., Morales, G. D. C., Srivastava, A. K., Allen, K. E., Spinardi, J., Kyaw, M. H., et al. (2023) · Journal of Global Health · doi:10.7189/jogh.13.06051 · Cited by 10
Han, Y., Liu, P., Qiu, Y., Zhou, J., Liu, Y., Hu, X., Yang, Q., Huang, R., Wen, X., Song, H., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146267 · Cited by 10
Howerton, E., Ferrari, M. J., Bjørnstad, O. N., Bogich, T. L., Borchering, R. K., Jewell, C., Nichols, J. D., Probert, W. J. M., Runge, M. C., Tildesley, M. J., et al. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009518 · Cited by 11
Deep dissection of the antiviral immune profile of patients with COVID-19
Atanackovic, D., Avila, S. V., Lutfi, F. U., de Miguel‐Pérez, D., Fan, X., Sanchez‐Petitto, G., Mause, E. R. V., Siglin, J., Baddley, J. W., Mannuel, H. D., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02852-1 · Cited by 10
Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers
Bayhan, G. İ., & Güner, R. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.2020017 · Cited by 10
Morris, S. R., Anjan, S., Pallikkuth, S., Frattaroli, P., Courel, S. C., Fernandez, A., Natori, A., Abbo, L. M., Pahwa, S. G., Guerra, G., et al. (2022) · Transplant Infectious Disease · doi:10.1111/tid.13827 · Cited by 10
Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serology
Perkmann, T., Köller, T., Perkmann‐Nagele, N., Ozsvár-Kozma, M., Eyre, D. W., Matthews, P. C., Bown, A., Stoesser, N. E., Breyer, M., Breyer‐Kohansal, R., et al. (2022) · Journal of Clinical Pathology · doi:10.1136/jcp-2022-208171 · Cited by 10
Self-citationSeekircher, L., Siller, A., Astl, M., Tschiderer, L., Wachter, G. A., Pfeifer, B. E., Huber, A., Gaber, M., Schennach, H., & Willeit, P. (2022) · Viruses · doi:10.3390/v14091877 · Cited by 10
Kostin, N. N., Bobik, T. V., Skryabin, G. A., Simonova, M. A., Knorre, V. D., Abrikosova, V. A., Mokrushina, Y. A., Smirnov, I. V., Aleshenko, N. L., Kruglova, N. A., et al. (2022) · Acta Naturae · doi:10.32607/actanaturae.11776 · Cited by 10
Denaro, M. F., Ferro, E., Barrano, G., Meli, S., Busacca, M., Corallo, D., Capici, A., Zisa, A., Cucuzza, L., Gradante, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054742 · Cited by 10
Olearo, F., Nörz, D. S., Hoffman, A., Grunwald, M., Gatzemeyer, K., Christner, M., Both, A., Campos, C. E. B., Braun, P., Andersen, G., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.08.047 · Cited by 10
Vaccination of Pregnant Women Against COVID-19
Abu-Raya, B. (2021) · NeoReviews · doi:10.1542/neo.22-9-e570 · Cited by 10
Colucci, M., Santis, E. D., Totti, B., Miroballo, M., Tamiro, F., Rossi, G., Piepoli, A., Vincentis, G. D., Greco, A., Mangia, A., et al. (2021) · Vaccines · doi:10.3390/vaccines9101207 · Cited by 10
Kelsen, S. G., Braverman, A. S., Aksoy, M. O., Hayman, J. A., Patel, P. S., Rajput, C., Zhao, H., Fisher, S. G., Ruggieri, M. R., & Gentile, N. (2022) · JCI Insight · doi:10.1172/jci.insight.155889 · Cited by 10
Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection
Mencacci, A., Gili, A., Camilloni, B., Bicchieraro, G., Spaccapelo, R., Bietta, C., & Stracci, F. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.07.013 · Cited by 10
Theel, E. S. (2021) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2021.10.006 · Cited by 10
Chhatwal, J., Xiao, J., Mueller, P. P., Adee, M. G., Dalgic, O. O., Ladd, M. A., Ayer, T., & Linas, B. P. (2021) · medRxiv · doi:10.1101/2021.08.11.21261845 · Cited by 10
Jantarabenjakul, W., Chantasrisawad, N., Puthanakit, T., Wacharapluesadee, S., Hirankarn, N., Ruenjaiman, V., Paitoonpong, L., Suwanpimolkul, G., Torvorapanit, P., Pradit, R., et al. (2021) · medRxiv · doi:10.1101/2021.08.27.21262721 · Cited by 10
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVPreprint
Alrubayyi, A., Gea‐Mallorquí, E., Touizer, E., Hameiri‐Bowen, D., Kopycinski, J. T., Charlton, B. G., Fisher-Pearson, N., Muir, L., Rosa, A., Roustan, C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-309746/v1 · Cited by 12
Sabetian, G., Shahriarirad, S., Moghadami, M., Asmarian, N., Askarian, M., Askarian, M., Haghighi, L. H. F., & Javadi, P. (2021) · Research Square · doi:10.30476/ijms.2023.97708.2951 · Cited by 10
Modelling the impact of hybrid immunity on future COVID-19 epidemic waves
Le, T. P., Abell, I. R., Conway, E. J., Campbell, P. T., Hogan, A. B., Lydeamore, M., McVernon, J., Müeller, I., Walker, C. R., & Baker, C. M. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09282-4 · Cited by 10
The First Case of Immunity Loss and SARS-CoV-2 Reinfection by the Same Virus Lineage in Amazonia
Ferrante, L., Livas, S., Steinmetz, W. A. C., Almeida, A. C. L., Leão, J., Vassão, R. C., Tupinambás, U., Fearnside, P. M., & Duczmal, L. H. (2021) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-021-01084-7 · Cited by 9
Alfano, G., Fontana, F., Morisi, N., Giaroni, F., Mori, G., Guaraldi, G., Magistroni, R., Cappelli, G., & Modena Covid‐19 Working Group (MoCo19) (2021) · Hemodialysis International · doi:10.1111/hdi.12963 · Cited by 9
Update Alert 8: Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers
Chou, R., Dana, T., Buckley, D., Selph, S., Fu, R., & Totten, A. M. (2021) · Annals of Internal Medicine · doi:10.7326/l21-0143 · Cited by 9
Evaluating immunity to SARS‐CoV ‐2 in nursing home residents using saliva IgG
Katz, M. J., Heaney, C. D., Pisanic, N., Smith, L., Bigelow, B. F., Sheikh, F., Boudreau, A., Kruczynski, K. L., Hsu, Y., Salinas, A. B., et al. (2022) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17660 · Cited by 9
Huynen, P., Grégoire, C., Gofflot, S., Seidel, L., Maes, N., Vranken, L., Delcour, S., Moutschen, M. P., Hayette, M., Kolh, P. H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09215-8 · Cited by 9
Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques
Willcox, A. C., Sung, K., Garrett, M. E., Galloway, J., O’Connor, M. A., Erasmus, J. H., Logue, J. K., Hawman, D. W., Chu, H. Y., Hasenkrug, K. J., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010155 · Cited by 9
de la Torre, J. C. G., Cáceres-DelAguila, J. A., Muro-Rojo, C., Cruz-Escurra, N. D. L., Corzo, C. A. C., Hueda-Zavaleta, M., Siles, D. A., & Benites-Zapata, V. A. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7050066 · Cited by 10
Quantification of a COVID-19 Antibody Assay Using a Lateral Flow Test and a Cell Phone
Thompson, P., Bovolato, A. L. D. C., Ibáñez-Redín, G., & Brolo, A. G. (2022) · Chemosensors · doi:10.3390/chemosensors10070234 · Cited by 9
Reinfection and Reactivation of SARS-CoV-2
Dowran, R., Damavandi, A. R., & Mokhtari‐Azad, T. (2022) · Future Virology · doi:10.2217/fvl-2021-0212 · Cited by 9
SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States
Wang, H., Wright, T., Everhart, K., Oyeniran, S. J., Mejías, A., & Leber, A. L. (2023) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piad017 · Cited by 9
Al-Haideri, M. T., Mohammad, T. A. M., Darvishzadehdeldari, S., Karbasi, Z., Alimohammadi, M., Faramarzi, F., Khorasani, S., Rasouli, A., Tahmasebi, S., Darvishi, M., et al. (2023) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14713 · Cited by 9
Mink, S., Saely, C. H., Frick, M., Leiherer, A., Drexel, H., & Fraunberger, P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12155068 · Cited by 9
Swadźba, J., Panek, A., Wąsowicz, P., Anyszek, T., & Martin, E. (2024) · Vaccines · doi:10.3390/vaccines12050471 · Cited by 11
The impact of COVID ‐19 on obesity services across Europe: A physician survey
Nather, K., Bolger, F., DiModica, L., Fletcher-Louis, M., Salvador, J., Pattou, F. N., Panton, U. H., & Cancino, A. (2021) · Clinical Obesity · doi:10.1111/cob.12474 · Cited by 9
Menon, V. P., Shariff, M. A., Perez-Gutierrez, V. A., Carreño, J. M., Yu, B., Jawed, M., Gossai, M., Valdez, E., Pillai, A., Venugopal, U., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051045 · Cited by 9
Caballero, N., Nieto, M. A., Suarez-Zamora, D. A., Moreno, S., Remolina, C. I., Durán, D., Vega, D., Rodríguez-Urrego, P. A., Gómez, C. P., Rojas, D. P., et al. (2022) · IJID Regions · doi:10.1016/j.ijregi.2022.03.013 · Cited by 9
Schubert, L., Koblischke, M., Schneider, L., Porpaczy, E. A., Winkler, F., Jaeger, U., Blüml, S., Haslacher, H., Burgmann, H., Aberle, J. H., et al. (2022) · Cancers · doi:10.3390/cancers14081962 · Cited by 9
Facciuolo, A., Scruten, E., Lipsit, S., Lang, A. L. S., Cates, Z. P., Lew, J. M., Falzarano, D., Gerdts, V., KUSALIK, A. J., & Napper, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-12032-8 · Cited by 9
Benchmarking SARS CoV-2 Infection in the Workplace to Support Continuity of Operations
Iddins, B. O., Waugh, M. H., Buck, B., Cato, T., Graham, D. E., Attia, K., Jones, D. R., Partin, A. M., Shourbaji, R., & Wesh, C. (2021) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002188 · Cited by 9
Novello, S., Terzolo, M., Berchialla, P., Gianetta, M., Bianco, V., Arizio, F., Brero, D., Perini, A. M. E., Boccuzzi, A., Caramello, V., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-04279-4 · Cited by 9
Rapid waning of protection induced by prior BA.1/BA.2 infection against BA.5 infectionPreprint
Malato, J., Ribeiro, R. M., Fernandes, E., Leite, P. P., Casaca, P., Antunes, C., Fonseca, V. R., Gomes, M. C., & Graça, L. (2022) · medRxiv · doi:10.1101/2022.08.16.22278820 · Cited by 9
Freedenberg, A. T., Pan, C., Diehl, W. E., Romeiser, J. L., Hwang, G., Leiton, C. V., Muecksch, F., Shroyer, K. R., & Bennett‐Guerrero, E. (2021) · Transfusion · doi:10.1111/trf.16283 · Cited by 9
Sánchez‐Montalvá, A., Fernández‐Naval, C., Antón, A., Durà-Miralles, X., Vimes, A., Silgado, A., Velásquez-Orozco, F., Pereiro, J. E., Salvador, F., Pumarola, T., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091968 · Cited by 8
Manica, M., Pancheri, S., Poletti, P., Giovanazzi, G., Guzzetta, G., Trentini, F., Marziano, V., Ajelli, M., Zuccali, M. G., Benetollo, P. P., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab556 · Cited by 8
Comelli, A., Consonni, D., Lombardi, A., Viero, G., Oggioni, M., Bono, P., Renteria, S. U., Ceriotti, F., Mangioni, D., Muscatello, A., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168748 · Cited by 8
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
Mohanraj, D., Baldwin, S., Singh, S., Gordon, A., & Whitelegg, A. M. E. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104501 · Cited by 10
Duarte, N., Arora, R. K., Bennett, G., Wang, M., Snyder, M. P., Cooperstock, J. R., & Wagner, C. E. (2022) · PLOS Digital Health · doi:10.1371/journal.pdig.0000100 · Cited by 10
Al-Hatamleh, M. A. I., Abusalah, M. A. H., Hatmal, M. M., Alshaer, W., Ahmad, S., Mohd-Zahid, M. H., Rahman, E. N. S. E. A., Yean, C. Y., Alias, I. Z., Uskoković, V., et al. (2022) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2022.11.007 · Cited by 8
Tavakoli, A., Lotfı, F. H., Lotfi, M., Bayati, M., Seif, M., Salesi, M., Emadi, M., Keshavarz, K., & Delavari, S. (2023) · PubMed Central · doi:10.30476/ijms.2022.94615.2598 · Cited by 8
Yap, D. Y. H., Fong, C. H.-Y., Zhang, X., Ip, J. D., Chan, W.-M., Chu, A. W., Chen, L., Zhao, Y., Chan, B. P.-C., Luk, K. S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47130-8 · Cited by 8
A stronger antibody response in increased disease severity of SARS-CoV-2
de Oliveira, M. I., Aciole, M. R., Neves, P. A. F., Silva, V. P. O. E., Silva, M. P. O. E., de Lorena, V. M. B., & de Araújo, P. S. R. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-023-08923-4 · Cited by 9
O’Reilly, S. R., Byrne, J., Feeney, E. R., Mallon, P. W. G., & Gautier, V. (2024) · Vaccines · doi:10.3390/vaccines12101089 · Cited by 8
Marchand, A., Roulland, I., Semence, F., & Ericsson, M. (2021) · Bioanalysis · doi:10.4155/bio-2020-0318 · Cited by 8
Zaffina, S., Lanteri, P., Gilardi, F., Garbarino, S., Santoro, A., Vinci, M. R., Carsetti, R., Scorpecci, A., Raponi, M., Magnavita, N., et al. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.666468 · Cited by 8
Nine-month course of SARS-CoV-2 antibodies in individuals with COVID-19 infection
Türkkan, A., Saglik, I., Turan, C. A., Sahin, A., Akalin, H., Ener, B., Kara, A., Celebi, S., Sahin, E., & HACIMUSTAFAOĞLU, M. K. (2022) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02716-x · Cited by 8
Padhiar, N. H., Liu, J., Wang, X., Wang, X., Bodnar, B. H., Khan, S., Wang, P., Khan, A. I., Luo, J. J., Hu, W., et al. (2022) · Vaccines · doi:10.3390/vaccines10060858 · Cited by 8
Prevalence of SARS-CoV-2 antibodies after the Omicron surge, Kingston, Jamaica, 2022
Anzinger, J. J., Cameron-McDermott, S. M., Phillips, Y. Z. R., Mendoza, L., Anderson, M., Cloherty, G., Strachan-Johnson, S., Lindo, J., & Figueroa, J. P. (2022) · Journal of Clinical Virology Plus · doi:10.1016/j.jcvp.2022.100124 · Cited by 8
Features of HLA class I expression and its clinical relevance in SARS‐CoV‐2: What do we know so far?
Bouayad, A. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2236 · Cited by 9
Rees, E. M., Waterlow, N. R., Lowe, R., & Kucharski, A. J. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16701.1 · Cited by 8
Gallichotte, E. N., Nehring, M., Young, M. C., Pugh, S., Sexton, N. R., Fitzmeyer, E. A., Quicke, K. M., Richardson, M., Pabilonia, K. L., Ehrhart, N. P., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00224-21 · Cited by 8
Kageyama, T., Tanaka, S., Etori, K., Hattori, K., Miyachi, K., Kasuya, T., Iwamoto, T., Ikeda, K., Igari, H., Yokote, K., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2022.02.045 · Cited by 8
Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
Park, H., Park, M. S., Seok, J. H., You, J., Kim, J., Kim, J., & Park, M. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-1598-x · Cited by 8
Repairing our broken relationship with the vaccine hesitant
Dainton, C. J., & Wong, J. (2022) · Canadian Family Physician · doi:10.46747/cfp.6803211 · Cited by 8
Hausfater, P., Boutolleau, D., Lacombe, K., Beurton, A., Dumont, M., Constantin, J., Ghosn, J., Combes, A., Cury, N., Guedj, R., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-10945-y · Cited by 8
Domènech-Montoliu, S., Puig‐Barberà, J., Pac-Sa, M. R., Vidal-Utrillas, P., Latorre-Poveda, M., Rio-González, A. D., Ferrando-Rubert, S., Ferrer-Abad, G., Sanchéz-Urbano, M., Aparisi-Esteve, L., et al. (2021) · COVID · doi:10.3390/covid1010006 · Cited by 8
Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2
Kršák, M., Harry, B. L., Palmer, B. E., & Franco‐Paredes, C. (2021) · Viral Immunology · doi:10.1089/vim.2021.0054 · Cited by 8
When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak
Taoufik, Y., de Herve, M.-G. D. G., Corgnac, S., Dürrbach, A., & Mami‐Chouaib, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692598 · Cited by 7
Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
Al-Haddad, F., Abdulkareem, A., Alsharrah, D., Alkandari, A., Bin‐Hasan, S., Al-Ahmad, M. S., Hashemi, H. A., & Alghounaim, M. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056371 · Cited by 7
Erber, A. C., Wagner, A., Karachaliou, M., Jeleff, M., Kalafatis, P., Kogevinas, M., Pepłońska, B., Santonja, I., Schernhammer, E. S., Stockinger, H. S. J., et al. (2022) · Journal of Biological Rhythms · doi:10.1177/07487304221132355 · Cited by 7
Ward, V., Wei, J., Gordon, W., Barnes, E. J., Dunachie, S. J., Jeffery, K. J., Eyre, D. W., & O’Donnell, A.-M. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-066766 · Cited by 7
Self-citationNakamura, N., Kobashi, Y., Kim, K. S., Park, H., Tani, Y., Shimazu, Y., Zhao, T., Nishikawa, Y., Omata, F., Kawashima, M., et al. (2024) · PLOS Digital Health · doi:10.1371/journal.pdig.0000497 · Cited by 7
Metadata
- Authors
- Lumley, S. F., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., Peck, L. J., Ritter, T. G., de Toledo, Z., Warren, L., Axten, D., Cornall, R. J., Jones, E. Y., Stuart, D. I., Screaton, G., Ebner, D., Hoosdally, S., Chand, M., Crook, D. W., O’Donnell, A.-M., Conlon, C. P., Pouwels, K. B., Walker, A. S., Peto, T. E. A., Hopkins, S., Walker, T. M., Jeffery, K., & Eyre, D. W.
- Affiliations
- Public Health England (GB)
- From Oxford University Hospitals NHS Foundation Trust (S.F.L., N.E.S., P.C.M., S.C., T.J., F.W., L.W., D.A., A.-M.O., K.J.), Nuffield Department of Medicine (S.F.L., D.O., N.E.S., P.C.M., A.H., S.B.H., B.D.M., R.J.C., E.Y.J., D.I.S., G.S., D.E., S. Hoosdally, D.W.C., C.P.C., A.S.W., T.E.A.P., T.M.W.), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (N.E.S., P.C.M., S. Hoosdally, D.W.C., A.S.W., T.E.A.P., D.W.E.), the Kennedy Institute of Rheumatology Research (B.D...
- Corresponding author
- Eyre, David W.
- ORCID
- Lumley, Sheila F.
- Stoesser, Nicole E.
- Matthews, Philippa C.
- Hatch, Stephanie B.
- Marsden, Brian D.
- Peck, Liam J.
- Ritter, Thomas G.
- Cornall, Richard J.
- Stuart, David I.
- Screaton, Gavin
- Ebner, Daniel
- Hoosdally, Sarah
- Chand, Meera
- Crook, Derrick W.
- Conlon, Christopher P.
- Pouwels, Koen B.
- Walker, A. Sarah
- Peto, Tim E.A.
- Hopkins, Susan
- Jeffery, Katie
- Eyre, David W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-02-11
- Volume
- 384
- Issue
- 6
- Pages
- 533-540
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC7781098
- OpenAlex
- W3117382778
- Cited by
- 940
- References
- 29
- Citations by year
- 2026: 7 · 2025: 26 · 2024: 53 · 2023: 103 · 2022: 299 · 2021: 434
- FWCI
- 28.01
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- medRxiv (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- U.K. Government
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 reinfection, healthcare workers, anti-spike IgG, seropositivity, seroconversion, asymptomatic infection, symptomatic infection, infection incidence, antibody status
- MeSH terms
- Seroconversion, COVID-19, SARS-CoV-2, Coronavirus Nucleocapsid Proteins, COVID-19 Nucleic Acid Testing, COVID-19 Serological Testing, Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Viral, Female, United Kingdom, Health Personnel, Humans, Immunoglobulin G, Longitudinal Studies, Male, Middle Aged, Recurrence, Incidence, Polymerase Chain Reaction, Young Adult, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
